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Abstract
The goal of this narrative review is to evaluate the efficacy of available questionnaires for assessing the outcomes of
‘‘continence difficulty’’ interventions and to assess the selected questionnaires concerning aspects of stigmatization.
The literature was searched for research related to urinary incontinence, as well as questionnaires and rating scale
outcome measurement tools. The following sources were searched: Cochrane Library, EMBASE, Medline, and PubMed.
The following keywords were used separately or in combination: ‘‘Urinary incontinence,’’ ‘‘therapy,’’ ’’treatment out-
come,’’ ‘‘patient satisfaction,’’ ‘‘quality of life,’’ ‘‘systematic reviews,’’ ‘‘aged 65þ years,’’ and ‘‘questionnaire.’’ The search
yielded 194 references, of which 11 questionnaires fit the inclusion criteria; 6 of the 11 questionnaires did not have any
stigma content and the content regarding stigma that was identified in the other five was very limited. A representative
model of how stigma impacts continence difficulty interventions was proposed. While the 11 incontinence specific
measurement tools that were assessed were well researched and designed specifically to measure the outcomes of
incontinence interventions, they have not been used consistently or extensively and none of the measures thoroughly
assess stigma. Further studies are required to examine how the stigma associated with continence difficulty impacts upon
health care interventions.
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Introduction
Urinary incontinence is a condition for which involun-
tary leakage of urine is objectively demonstrable.1
The prevalence of urinary incontinence is estimated to
be 5–10% among the general elderly population,
10–20% among those receiving home care, and at
least 50% among those individuals living in long-term
care institutions.2 In Canada, close to 1.5 million
people experience episodes of urinary incontinence, a
number that is bound to increase as the population
ages rapidly.3 Most studies indicate that women have
a higher prevalence of urinary incontinence than men,
due to differences in the structure of the male and
female urinary tracts. The causes of urinary incontin-
ence among women include childbirth, menopause,
obesity, presence of lower urinary tract symptoms and
decreased mobility. It is common for men to experience
urinary incontinence following a prostatectomy, as sug-
gested by the prevalence rate for men spiking from 5%
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to over 60% following this surgery.4 The literature
includes numerous definitions of incontinence and con-
tinence symptoms.5 For this study, we sought to assess a
range of continence questionnaires. Consequently, we
selected the term ‘‘continence difficulties’’ (CD) to
embrace symptoms of both urinary incontinence as well
as urinary continence, which includes conditions that are
not necessarily associated with involuntary leakage.
CD can lead to various negative psychosocial out-
comes. Individuals with this condition have reported
feelings of powerlessness,6 that serve as an obstacle to
engaging in activities of daily living7 and social partici-
pation.8,9 While some reports associate CD with reduced
self-esteem,10 other authors have reported that no asso-
ciation is found between CD and self-esteem.8
Despite common misconceptions that CD is inevit-
able and untreatable,11 the evolution of treatment
options over the past few decades has resulted in the
development of various conservative, pharmacological,
surgical, and technological treatments. Urinary CD can
be eliminated or improved in the vast majority of
patients (70%, according to this survey).3 With alterna-
tives comes a responsibility to assess the efficacy of these
treatments so that future clients may make informed
health-care decisions.
Stigma
A topic that has received scant attention in the research
literature is the stigma associated with CD. Individuals
are stigmatized when they possess, or are thought to
possess, an attribute or characteristic that conveys a
social identity that is devalued in a particular social
context.12 Stigmatization is a social phenomenon,
whereby two groups of people exist: insiders, those
who have a stigmatizing trait; and outsiders, those
who do not have the trait. In social settings, outsiders
may recognize that another individual possesses a char-
acteristic that sets them apart, potentially prompting
the devaluation of the insider. Stigma is fundamentally
a threat to one’s self-identity.13
Jones et al.14 proposed that the nature of stigmatiza-
tion may be influenced by six stigma dimensions (see
Table 1). Several of these dimensions have been shown
to be relevant to the stigma associated with CD.15 Of
these dimensions of stigma, Crocker et al.12 proposed
that concealability and origin are the most influential in
terms of giving rise to stigmatization in general.
Contemporary theorists identify three types of
stigma. Perceived-stigma is fear and worry of being sub-
jected to a stigmatizing event.16 Self-stigma is directing
prejudicial attitudes inwards to one’s self.17 Finally,
enacted-stigma includes episodes of discrimination
based on a stigmatizing attribute.18 There is great vari-
ability in the stigma process,19 such that stigmatization
may potentially lead to both adaptive or maladaptive
responses. For example, an insider who perceives a
stereotype to be unreasonable,17 may respond con-
structively to stigmatization.20
In Western societies, we are socialized to understand
that elimination of bodily waste is a private matter that
should be done in a tidy way.7 Failure to do so risks
being stigmatized.21 Individuals who present CD symp-
toms may be perceived as ‘‘different’’ and are commonly
stereotyped as frail, dependent, incompetent or simply
old.7 CD is associated with both old age and young age.
CD threatens one’s adult status.22 Individuals with CD
may be both embarrassed and shamed by having
CD.7,21,23 Urinary incontinence symptoms, including
daytime frequency, urgency, and nocturia are also stig-
matizing, as they are socially disruptive indications of
loss of control over bodily functions.5
Responses to stigmatization vary.17 It is common for
individuals with CD (a concealable trait) to withdraw
from social participation and conceal identifiers of their
condition.24,25 Brittain and Shaw26 found that stroke
survivors with CD were embarrassed and fearful of
leakages and odour, resulting in isolating tendencies.
Disengagement is associated with elevated levels of
stress,19 perhaps because attempts to conceal may be
thwarted by accidents, smells, and the visibility of the
management products used to deal with the condition.
Denial, concealment, and reluctance to acknowledge
health status all potentially serve to prevent or delay
entry into treatment, thereby decreasing the possibility
for successful intervention.6,27–30 Individuals with CD
may be reluctant and embarrassed to consult health
care practitioners concerning treatment options,31,32
such that the proportion of individuals who seek out
treatment options is in the order of 5–25%.4,33
The numerous effects of CD on a person’s psycho-
logical and social wellbeing make it challenging to
Table 1. Dimensions of stigma.
Dimension Distinguishing characteristic
Concealability Is the trait apparent to others?
The course of the mark Does the trait become more
prominent over time?
Disruptiveness Does the trait impede social
interactions?
Aesthetics Is the trait unattractive to
others?
Origin Is the trait individual perceived
to be responsible in acquiring
or creating the trait?
Peril Is the trait perceived to be dan-
gerous to others in the social
settings?
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measure the relative success of a particular treatment.
For example, it is prudent to ask oneself if reducing the
number of leakage episodes constitutes a better treat-
ment success than a client’s own perception of dryness.
The former is an objective measure, acquired by using a
pad weight test, for example, while the latter is a sub-
jective measure.34 Unlike objective measures, subjective
questionnaires are highly versatile in their production
and administration. But versatility raises concerns
about accuracy.35 In order to eliminate bias, questions
such as ‘‘who should ask the questions,’’ ‘‘to whom
should questions be asked,’’ ‘‘what questions should
be asked’’ and ‘‘when should they be asked’’ need to
be considered when determining the efficiency of a
questionnaire.35 Hence, a combination of both subject-
ive and objective measures is most likely the best way to
assess the efficacy and effectiveness of CD treatments.
With these issues in mind, the purpose of this review
was to examine stigma-related content in a selection of
popular instruments for assessing the outcomes of urin-
ary CD interventions. A characterization of each meas-
ure is presented, followed by an identification and
evaluation of stigma-related items.
Methods
The method used was a narrative (or traditional) litera-
ture review. It was designed to provide a comprehensive
overview of the topic area, highlight significant areas of
research, and identify gaps in the research.
We sought to answer the following questions: In
research on adults who have undergone an intervention
(behavioral, drugs, surgery, and/or management prod-
ucts) to help manage their urinary incontinence, what
instruments were used to measure continence improve-
ment? What were the stigma-related contents of these
instruments?
The population of interest was individuals aged 65þ
with urinary incontinence. The intervention of interest
included any form of urinary incontinence measure-
ment tool. All types of study designs, methods, and
outcomes were considered, with an emphasis on rando-
mized controlled trials. The following sources were
searched: Cochrane Library, EMBASE, Medline, and
PubMed. Articles screened in had to contain the key-
words ‘‘Urinary incontinence,’’ ‘‘aged 65þ years,’’
‘‘therapy,’’ and ‘‘treatment outcome.’’ These articles
were then searched for each of the following keywords
separately, ‘‘patient satisfaction,’’ ‘‘quality of life,’’
‘‘systematic reviews,’’ and ‘‘questionnaire.’’
Literature selection
The first author manually searched relevant journal art-
icles if the abstracts made any mention of a
measurement tool that was used to assess outcomes
after a certain treatment for CD. All potential sources
for ‘‘gray literature’’ (unpublished or government
related technical documents) were searched. Books,
proceedings, and presentations were excluded. The
search was limited to sources published within the
past 15 years, from December 2000 to July 2015, in
English. Systematic reviews and meta-analyses were
also sought to compare the transparency and accuracy
of the assessment. Articles were included if they made
mention of a questionnaire outcome measurement tool
in the abstract. A research assistant read all of the
abstracts, then compiled a list of questionnaires and
scales that were used, along with corresponding refer-
ence IDs so as to track how often each measure was
used in studies. Only questionnaires dealing directly
with urinary CD were considered. Outcome measures
qualified for consideration either by having obvious
words such as ‘‘incontinence’’, ‘‘urinary tract’’, ‘‘urin-
ary symptom’’ in the questionnaire title, or being iden-
tified in other studies to be a specific outcome
measurement instrument for CD. Articles that fit
within the selection criteria described above were
traced back to their original publication, from which
details of their psychometric evaluation were extracted
and assessed.
Assessing questionnaires for stigma
At present a well-validated measure of self-stigma does
not exist. Even so, Van Brakel36 suggested that aspects
of the stigmatization process are quite similar across
health conditions, cultures and public health pro-
grammes. Thus, the development of a nonspecific (i.e.
generic) measure to assess health-related stigma may
one day be feasible. But until then, Van Brakel recom-
mended that a comprehensive assessment of stigma
associated with health conditions incorporate (ideally
in interview format) five aspects of health-related stig-
mas (the first two items seek to assess the social and
physical factors that precipitate stigmatization, and are
thus not relevant to the present discussion): (a) atti-
tudes of community members and groups (e.g. health
care providers) towards people who possess stigmatiz-
ing health conditions; (b) discriminatory services and
legislation; (c) perceived-stigma (i.e. fear of stigmatizing
event); (d) enacted stigma (i.e. episodes of discrimin-
ation); and (e) self-stigma (i.e. directing prejudicial atti-
tudes inwards).
Guidelines proposed by Van Brakel36 were employed
to conduct a critical review of CD quality of life out-
come measures for content relevant to the stigma asso-
ciated with CD. Van Brakel proposed that a
comprehensive assessment of the insider perspective
on health related stigma should incorporate (ideally in
Southall et al. 3
interview format) an assessment of perceived-stigma,
self-stigma, and enacted-stigma. Definitions of these
constructs were operationalized, and a list of identifiers
was compiled to facilitate coding of stigma content (see
Table 2).
The questionnaires were analyzed by the first author
using content analysis.37 The objective was to ensure
that all items addressing any aspect of stigma be
assigned a code. Questionnaires were read item by
item, searching for content relevant to perceived-
stigma, enacted-stigma, and self-stigma.38 Selected
items were highlighted and assigned a meaningful
label, a process known as coding. As soon as all ques-
tionnaires had been coded once, the questionnaires
were re-read scrutinizing content and adjusting to the
coding scheme as needed. This process continued until
code list adjustments were no longer deemed necessary.
The next step was to test the reliability of the applica-
tion of codes. This was tested by comparing how the
first author coded three randomly selected question-
naires, with the coding of the same questionnaires per-
formed independently by an individual from outside the
research team. A researcher who had basic understand-
ing of outcomes research, and experience coding text-
based data was enlisted to complete this task. This
person was provided with the most up to date version
of the definitions and the three questionnaires. Inter-
rater reliability was established by calculating the
number of items similarly coded, divided by the total
number of items. An acceptable reliability score
(kappa) of 0.9439 was established on the first attempt.
Results
The search yielded 194 references. Of these, 112 studies
described using a questionnaire to measure outcomes of
treatment for CD. Ten were randomized controlled
trials, and 102 were nonrandomized controlled trials
(cohort, case control, and case series). Drawing from
the abstracts of the 112 studies, a list of 44
questionnaires was compiled, 11 of which were
designed specifically for evaluating continence/incon-
tinence based on the aforementioned inclusion criteria.
Key features of the questionnaires are described in
Table 3. Their reliability and validity are summarized
in Table 4. Below is a brief description of the question-
naires and details of their stigma content (stigma con-
tent is summarized in Table 5).
Bristol female lower urinary tract symptoms
questionnaire
The Bristol female lower urinary tract symptoms
(BFLUTS) questionnaire was developed by Jackson
et al.42 to assess female patients’ severity of incontin-
ence and its impact on quality of life. Consisting of 19
questions, items are grouped by symptoms of CD,
sexual matters, and lifestyle. Stigma: BFLUTs does
not include content relevant to perceived- or self-
stigma. However, the developers recommended in-
depth interviews to probe patients’ understanding of
the questionnaire and their responses. During this inter-
view, patients may choose to describe previous experi-
ences of enacted-stigma.
Incontinence impact questionnaire
The incontinence impact questionnaire (IIQ) was devel-
oped by Shumaker et al.43 to assess the impact of stress
CD on the everyday lives and emotions of women. The
IIQ consists of 30 questions among subscales of phys-
ical activity, travel, social relationships, and emotional
health. Stigma: Two IIQ items are pertinent to per-
ceived-stigma: Item W (Does fear of odor restrict your
activities?) and Item X (Does fear of embarrassment
restrict your activities?). Both questions assess emotions
associated with symptomology and the potential of
being devalued by others. Three IIQ items address
self-stigma: Item Z (Does your problem cause you to
experience fear?); Item AC (Does your problem cause
Table 2. Definitions, identifiers and instructions for the coding process.
Construct Definition Additional notes
Perceived-stigma fear or worries of being discriminated against
(as well as circumstances and events that may
lead to being discriminated against) because
of UI.
Must be fears or worries concerning future events
Self-stigma Self-devaluations/feelings associated with UI
(shame, blame, embarrassment, hopelessness,
guilt and fear of discrimination) result in
‘products’ including secrecy, withdrawal and/or
avoidance of certain activities, and depression.
The item must demonstrate that self-devaluation
results in ‘products’ Self-devaluation is code-
able (more helpless, less healthy, less confi-
dent). Whereas, negative QoL assessments
(eg, less enjoyment out of life is not codeable).
Enacted-stigma actual experiences of discrimination.
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you to experience depression?); and Item AD (Does
your problem cause you to experience embarrass-
ment?). Each of these questions assesses how the CD
condition has impacted upon relevant feelings and
emotions.
Urogenital distress inventory
The urogenital distress inventory (UDI) was developed
by Shumaker et al.43 to be a companion to the IIQ. The
UDI is used to assess the degree to which symptoms
associated with incontinence are bothersome to women,
and consists of 19 questions probing three domains:
symptoms related to stress urinary incontinence, detru-
sor overactivity, and bladder outlet obstruction.
Stigma: UDI does not include stigma relevant content.
Incontinence outcome questionnaire
The incontinence outcome questionnaire (IOQ) was
developed by Bjelic-Radisic et al.44 to assess the quality
of life of individuals following surgery for stress urinary
incontinence. The IOQ contains 27 questions related to
symptoms, complications, quality of life and
satisfaction, problems with urinary incontinence
before surgery, and demographic and treatment-related
information. Stigma: One IOQ item is pertinent to self-
stigma: Item IOQ14 (Change in feeling about body).
Post-operative reductions in body image may be a
reflection of self-stigma.
Incontinence quality of life
The incontinence quality of life (I-QOL) was developed
by Wagner et al.45 to assess the quality of life of persons
with urinary incontinence. The I-QOL consists of 22
items in the following subscales: avoidance and limiting
behaviors, psychosocial impacts and social embarrass-
ment. Stigma: Eight I-QOL items address perceived-
stigma (* denotes items which address future events
or occurrences that may lead to an incontinence acci-
dent): Item 1 (I worry about wetting myself); Item 4 (I
worry about coughing or sneezing because of my incon-
tinence*); Item 6 (I worry about where toilets are in
new places*); Item 11 (I worry about others smelling
urine on me); Item 17 (I worry about my incontinence
getting worse as I grow older*); Item 19 (I worry about
being embarrassed or humiliated because of my
Table 3. Key features of the selected questionnaires.
Questionnaire
Gender
designed for Type of CD Context/setting Domain
BFLUTS Female LUTS Everyday life Severity of incontinence, QOL impact
IIQ Female LUTS Everyday life Physical activity, Social relationships,
Travel, Emotional health




Detrusor over activity Bladder outlet
obstruction
IOQ Female SUI Individuals who have
undergone surgery
QOL impact, symptoms/complications
with UI before surgery
I-QOL No preference LUTS Everyday life QOL impact, Physical impact,
Psychosocial impact, Social
embarrassment
ICIQ-UI-SF No preference SUI Clinical care, Everyday life QOL impact, Severity of urinary loss
KHQ Female SUI Clinical care, Everyday life Health perception, sleep/energy, QOL
impact, Physical and social limita-
tions, Social relationships, emotional
health
MUDI/MUSIQ Male LUTS Community-dwelling
individuals
Symptom severity, emotional health,
physical and social activities, social
relationships
Stamey UIC Female SUI Following urinary
surgical treatments
QOL impact, physical health
GSE-UI No preference LUTS Everyday life Self-efficacy
ISI Female LUTS/ SUI Clinical care Incontinence severity
BFLUTS: Bristol female lower urinary tract symptoms; IIQ: incontinence impact questionnaire; UDI: urogenital distress inventory; IOQ: incontinence
outcome questionnaire; I-QOL: incontinence quality of life; ICIQ-UI-SF: international consultation on incontinence questionnaire-urinary incontinence-
short form; KHQ: kings health questionnaire; MUDI: male urogenital distress inventory; MUSIQ male urinary symptom impact questionnaire; GSE-UI:
geriatric self-efficacy index for urinary incontinence; ISI: incontinence severity index.
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incontinence); 24 (I worry about not being able to get
to the toilet on time*); and 28 (I worry about having sex
because of my incontinence*). These items relate to
perceived-stigma as they assess level of worry associated
with forthcoming and potentially embarrassing events.
Three I-QOL items are pertinent to self-stigma: Item 7
(I feel depressed because of my incontinence); Item 21
(My incontinence makes me feel like I’m not a healthy
person); and Item 22 (My incontinence makes me feel
helpless) are all relevant to self-stigma.
International consultation on incontinence
questionnaire-urinary incontinence-short form
The international consultation on incontinence
questionnaire-urinary incontinence-short form (ICIQ-
UI-SF) was developed by the International
Consultation on Incontinence.46 This four-item ques-
tionnaire provides a summary of the severity, impact
on quality of life and perceived cause of symptoms of
incontinence. Stigma: ICIQ-UI-SF does not include
stigma-relevant content.
Kings health questionnaire
The kings health questionnaire (KHQ) was developed by
Kelleher et al.47 to assess the influence that urinary
incontinence has on the quality of life of women. The
KHQ includes 21 questions concerning: perceived health
status, severity of urinary incontinence symptoms, phys-
ical limitations, social limitations, role limitations, emo-
tions, personal relationships, and sleep/energy. Stigma:
One KHQ item addresses perceived-stigma: Item 8D
(Worry in case you smell?). This item is relevant insofar
as assessing the level of worry individuals feel due to
future events that could be potentially embarrassing.
One KHQ item is pertinent to self-stigma: Item 6C
(Does your bladder problem make you feel bad about
yourself?). This item addresses relevant emotions asso-
ciated with CD-related difficulties.
Male urogenital distress inventory and male urinary
symptom impact questionnaire
The male urogenital distress inventory (MUDI) and
male urinary symptom impact questionnaire
(MUSIQ) were developed by Robinson et al.40 to
assess specific impact of lower urinary tract symptoms
(LUTS) on health-related quality of life for commu-
nity-dwelling men. MUDI and MUSIQ are an adapta-
tion of the commonly used UDI and IIQ.43 The MUDI
is a 27-item questionnaire which assesses presence of
LUTS, and the degree to which symptoms are bother-
some. The MUSIQ is a 32-item questionnaire that
prompts respondents to indicate the degree to which
LUTS affect emotional status and a range of activities,
relationships, and roles. Stigma: MUDI does not include
stigma relevant content. Similar to the IIQ, a number of
questions in the MUSIQ are pertinent to stigma. These
items include: Two MUSIQ items address perceived-
stigma: MUSIQ-25 (How much do you limit what you
do because of a fear of being embarrassed?) and
MUSIQ-26 (How much do you limit what you do
because of a fear of odor?). These items address future
events or occurrences that could lead to an incontinence
accident. Three MUSIQ items are relevant to self-stigma:
MUSIQ-12 (Have urinary symptoms changed the way
you feel about yourself?); MUSIQ-28 (How much do
urinary symptoms cause you to feel afraid?); MUSIQ-
32 (How much do urinary symptoms cause you to feel
Table 5. Summary of stigma content from identified measures.
Questionnaire Self stigma Perceived stigma Enacted stigma
BFLUTS None None potentially in interview
UDI None None None
IIQ X, Z, AC, AD T, W None
IOQ IOQ14 None None
I-QOL 7, 21, 22, 1, 4, 6, 11, 17, 19, 24, 28 None
ICIQ-UI-SF None None None
KHQ 6C 8D None
MUDI-MUSIQ MUSIQ-12, MUSIQ-28, MUSIQ-32 MUSIQ-25, MUSIQ-26, None
Stamey None None None
GSE-UI None None None
ISI None None None
BFLUTS: Bristol female lower urinary tract symptoms; IIQ: incontinence impact questionnaire; UDI: urogenital distress inventory; IOQ:
incontinence outcome questionnaire; I-QOL: incontinence quality of life; ICIQ-UI-SF: international consultation on incontinence ques-
tionnaire-urinary incontinence-short form; KHQ: kings health questionnaire; MUDI: male urogenital distress inventory; MUSIQ male
urinary symptom impact questionnaire; GSE-UI: geriatric self-efficacy index for urinary incontinence; ISI: incontinence severity index.
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embarrassed?). These items address relevant emotions
associated with CD symptoms.
Stamey urinary incontinence scale
Stamey48 developed the Stamey Urinary Incontinence
Scale to be a grading scale for the evaluation of stress
urinary incontinence. The scale can be used to gauge
improvement in incontinence following various treat-
ments. Stigma: The Stamey Urinary Incontinence
Scale does not include stigma relevant content.
Geriatric self-efficacy index for urinary incontinence
The geriatric self-efficacy index for urinary incontinence
(GSE-UI) was developed by Tannenbaum et al.49 to
assess self-efficacy for reducing or preventing urinary
incontinence. The developers applied the concepts of
Bandura’s Guide for Constructing Self-Efficacy
Scales50 such that all items began with ‘‘How confident
are you that you can. . .’’. Stigma: GSE-UI does not
include stigma relevant content.
Incontinence severity index
The incontinence severity index (ISI) was developed by
Sandvik et al.41 to produce a valid epidemiological
measure of female incontinence severity. The ISI is
composed of two questions: (1) How often do you
experience urinary leakage?; (2) How much urine do
you lose each time? Stigma: Neither of the ISI items
addresses stigma.
Discussion
Analyses revealed that more than half (six) of the
measures do not have any stigma content (i.e.
BFLUTS; UDI; ICIQ-UI-SF; Stamey; GSE-UI; ISI).
Four of the measures address perceived-stigma (IIQ;
I-QOL; KHQ; MUDI- MUSIQ). The I-QOL had the
greatest number of perceived-stigma items. Whereas,
five measures address self-stigma (IIQ; IOQ; I-QOL;
KHQ; MUDI- MUSIQ). Only the BFLUTS recom-
mends conducting an interview with individuals as a
way to supplement information provided by the ques-
tionnaire, and could thus serve as a way to examine
enacted-stigma.
Four points are noteworthy concerning these find-
ings. First, there is a conspicuous lack of content that
seeks to assess attitudes about CD treatments, and how
stigma may impact these attitudes. In their current
format, the measures are unable to assess key ques-
tions, such as ‘How do attitudes about CD manage-
ment products impact upon intervention outcomes?’
Second, the questionnaires that do contain stigma
content only address the negative impacts of stigma-
tization on the individual. Recall that individuals may
have adaptive responses to stigmatization. Therefore, it
is conceivable that an individual with CD may never
feel shame about their condition, or may come to terms
with CD after some time. At present, existing CD out-
come measures do not adequately address positive
stigma. Third, there is a need for opportunities to
assess enacted-stigma. Only BFLUTS provides a
means to assess enacted-stigma by recommending that
interviews be conducted with individuals, to uncover
how past experiences of stigmatization may impact
quality of life outcomes. Fourth, concerning the
gender specific nature of IIQ and UDI, and MUSIQ
and MUDI, the subscales covered by these measures
appeared to be very similar, which raises questions of
how the expressions of CD stigma may be similar or
different across gender. Moreover, one wonders if there
is a need to further personalize questionnaires to be
more gender specific, or whether a gender-neutral
approach would perform just as well as a gender-
specific approach.
Representation of CD stigma impacts CD
intervention
To aid in the conceptualization of CD, and perhaps the
eventual incorporation of stigma items into CD inter-
vention outcome measures, a representative model
of how stigma impacts CD intervention is proposed.
The representation (Figure 1) portrays accepted infor-
mation concerning health-related stigma (drawn from a
variety of health disciplines), and offers an approxima-
tion of how stigma factors may interact to impact upon
CD intervention outcomes. This representation is not
intended to be a comprehensive conceptual framework;
rather, it is intended to be a starting point to initiate a
dialogue and aid in the identification of stigma items
for inclusion in CD quality of life outcomes measures.
A key assumption associated with this model is that all
clients will access health care, employ services and be
impacted by their use (i.e. outcomes).
The model (see Figure 1) illustrates the interaction
between the individual, health care provider and soci-
etal inputs of stigma. The centre box portrays a typical
chronology, from onset of CD, to help seeking for
symptoms, leading to intervention outcomes. The
oval-shaped items that surround the central box serve
to moderate medical, rehabilitation, and self-directed
interventions to address CD difficulties. These moder-
ators include: relevant CD stereotypes, self-stigma,
participation in activities of daily life, previous
instances of enacted stigma and significant others’ atti-
tudes about CD. It is assumed that interactions
between the central box and the moderators, and the
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moderators themselves vary greatly (as depicted with
the ‘þ/-’ symbols). Also, although it is not immediately
obvious upon inspecting the model, it is assumed that
all moderators may influence any of the four landmarks
in the central box (e.g. participation in activities of daily
life may impact upon CD intervention outcome).
Prior to the onset of CD, in early childhood, indi-
viduals learn relevant CD stereotypes from community
members and significant others, and develop their own
attitudes about CD issues.7 Following the onset of CD,
the individual may be conflicted by the knowledge that
she or he now possesses a trait that she or he had
once ridiculed,17 which may initiate a process of self-
stigmatization.7,21,23 At some point, the individual real-
izes that they need to use CD management products
and or seek professional consultation for their CD con-
dition. Seeking for help may be delayed if the individual
self-stigmatizes, or has had previous instances of enacted
stigma.6,27,30 Individuals may be reluctant to access
health care and adhere to recommended treatments
due to the stereotypes associated with CD. Help-seek-
ing may lead to self-stigma or prejudicing from others.
Consultations with health professionals may be another
potentially stigmatizing situation, if practitioners do
not perceive CD to be a treatable condition.21,51
Finally, intervention outcomes (e.g. product satis-
faction, participation in activities of daily life and
well-being) may be impacted by previous instances of
perceived-stigma, self-stigma, and enacted-stigma. In
particular, the balance between confidence that one
can successfully participate in activities of daily living
versus fears and worries of accidents and stereotyping
(i.e. perceived-stigma).
Implications
There is ample evidence that many individuals who
have CDs are reluctant to seek help and to engage in
recommended treatment regimens. These individuals
are, in effect, foregoing rehabilitation services that
could possibly improve their quality of life. We believe
that stereotyping and stigmatization play a critical role
in this reluctance to access. Across numerous health
conditions and according to the literature reviewed in
this paper, stigma has been shown to impede recogni-
tion and early identification of health conditions, and
serve as a barrier to help-seeking, including for assistive
technology devices. In order to design, implement, and
evaluate effective rehabilitation intervention programs,
a better understanding of stigmatization is vital.
Over the past few decades, we have seen the devel-
opment of various treatment options for individuals
with incontinence. These treatments and management
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Figure 1. Model of effects of stigma on outcomes of CD interventions.CD: continence difficulty; Central box: typical chronology of
CD intervention and outcome; Oval-shaped items: factors that moderate medical, rehabilitation, and self-directed interventions that
address CD difficulties, known as ‘‘moderators’’; þ/-: represents the varying interactions between the central box and moderators,
and the moderators themselves.
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those living with CD symptoms. If consumers are to
make informed health-care decisions concerning these
treatments, it is necessary to assess their efficacy. In the
present review, we uncovered 11 incontinence-specific
outcome measurement tools. The identified instruments
are reasonably well-researched, designed principally to
assess the health-related quality of life impact of incon-
tinence symptoms. But they have not been used consist-
ently or extensively in research to measure effectiveness
of management products, and none of the measures
completely and thoroughly assesses stigma.
To achieve a standardized, objective, and measur-
able assessment of the psychosocial outcomes attribut-
able to the use of management products, specifically
designed tools are required. Our team has begun to
explore if one particular measure (i.e. PIADS) requires
modifications to address the needs of continence device
users and to inform any subsequent item development.
The PIADS is a 26-item self-report questionnaire called
the (PIADS).52 In a recent progress report,53 we
reported that the PIADS largely addresses many of
the fundamental psychosocial elements of adults who
have CDs. Development of a version of the PIADS for
continence, the C- PIADS, is underway and is likely to
contain new items. This measure, once completed, aims
to provide a valid and reliable measure of psychosocial
outcomes attributable to assistive technology use that is
sensitive to stigma.
Limitations of this review
A narrative review may be susceptible to bias because
of the search methods criteria for selection. It is pos-
sible that the search omitted significant sections of the
literature.
Conclusion
There is an increasing range of procedures, manage-
ment products, medications, and strategies that individ-
uals with CD may choose from to address CD-related
needs. Yet, the extent to which these services are bene-
ficial remains in question. There is little doubt that CD
stigma is a determinant of CD intervention outcomes.
For some people, there is embarrassment and shame
associated with having CD, and these emotions likely
play a role (albeit, as yet, not clearly defined) in inter-
vention outcomes. Clinicians should be aware of CD
stigma, and may be watchful for manifestations of per-
ceived- and self-stigma, and are encouraged to enter
into discussions with their clients to better understand
how previous instances of discrimination may affect
current practices. Further studies are required to exam-
ine how the stigma associated with CD impacts upon
health care interventions. There is a need for a
comprehensive examination and characterization of
the stigma associated with CD, to better understand
how stereotypes, perceived-stigma, self-stigma impact
upon intervention outcomes. This would be a first
step toward the design of device-specific outcome meas-
ures that take into account social stigma.
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